CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

Clinical trial NCT07019363 · RECRUITING

Trial details

NCT number: NCT07019363
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Adjuvant Therapy

Start date: 2025-06-15
Primary completion: 2029-05-15
Enrollment: 1903

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.